GNH USA

Europe — EMA

Lamivudina Aurovitas

GNH USA supplies Lamivudina Aurovitas (Lamivudine), a nucleoside reverse transcriptase inhibitor for HIV infection and chronic hepatitis B.

Lamivudine

Request sourcing

1
Pack/s

What is Lamivudine?

Lamivudine, the active ingredient in Lamivudina Aurovitas, is a nucleoside reverse transcriptase inhibitor presented as an oral dosage form for oral use. It is used to treat Human Immunodeficiency Virus (HIV) infection and chronic hepatitis B infection in adults and children. GNH USA supplies Lamivudina Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Lamivudine used for?

Lamivudina Aurovitas is a nucleoside reverse transcriptase inhibitor indicated for viral infections affecting the immune and hepatic systems. - HIV infection: reduces viral load and helps restore immune function. - Chronic hepatitis B infection: suppresses HBV replication and reduces liver inflammation. - Prevention of mother‑to‑child transmission of HIV: lowers the risk of vertical transmission when used in combination therapy.

What are the side effects of Lamivudine?

Lamivudina Aurovitas may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal discomfort. - Headache: transient cranial pain. - Fatigue: general feeling of tiredness. - Diarrhea: loose stools, usually self‑limiting.

Serious or Rare Side Effects: - Lactic acidosis: metabolic disturbance requiring immediate medical attention. - Severe hepatotoxicity: liver enzyme elevation or failure. - Pancreatitis: inflammation of the pancreas with abdominal pain.

What precautions apply to Lamivudine?

Before initiating therapy, clinicians should consider several safety measures. - Monitor liver function: regular testing is advised for patients with hepatic disease. - Assess renal function: dose adjustment may be required in renal impairment. - Screen for hepatitis B reactivation: periodic HBV DNA monitoring is recommended. - Counsel on pregnancy: the safety profile is not fully established; discuss risks with a healthcare provider. - Store at ambient temperature: keep below 25°C, protect from moisture and retain in original packaging.

What does Lamivudine interact with?

Lamivudina Aurovitas can interact with other medicines, influencing efficacy or toxicity.

Major Interactions (Avoid): - Didanosine: combined use increases risk of pancreatitis. - Stavudine: concurrent therapy may enhance mitochondrial toxicity. - Ribavirin: co‑administration can heighten hematologic toxicity.

Moderate Interactions (Monitor Closely): - Alcohol: may exacerbate liver injury. - Antacids: could affect lamivudine absorption if taken simultaneously. - Protease inhibitors: may alter lamivudine plasma concentrations.

Frequently asked questions

What is Lamivudina Aurovitas used for?+
Lamivudina Aurovitas contains lamivudine, an antiretroviral medication indicated for the treatment of Human Immunodeficiency Virus (HIV) infection and chronic hepatitis B infection. It helps lower viral load and improve immune function in HIV patients and suppresses hepatitis B virus replication in liver disease.
How does lamivudine work?+
Lamivudine is a nucleoside analogue that, after cellular phosphorylation, becomes an active triphosphate. This active form competes with natural nucleotides for incorporation into viral DNA by reverse transcriptase, causing premature chain termination and preventing the virus from replicating its genome.
What is the usual dose of lamivudine?+
The specific dose of lamivudine is determined by the prescribing clinician based on the patient’s condition, age, weight, renal function and other factors. Healthcare providers follow established guidelines and adjust the regimen as needed for optimal therapeutic effect.
Is lamivudine safe during pregnancy or breastfeeding?+
The safety of lamivudine in pregnancy and lactation has not been fully established. It should only be used if the potential benefit justifies the possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.
How do I order Lamivudina Aurovitas from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does lamivudine compare with other antiretroviral drugs?+
Lamivudine belongs to the nucleoside reverse transcriptase inhibitor (NRTI) class, offering a favorable safety profile and convenient oral administration. Compared with some older NRTIs, it has lower mitochondrial toxicity and is often combined with other agents to form highly effective combination regimens for HIV and hepatitis B.
What are the storage and handling requirements for Lamivudina Aurovitas?+
Lamivudina Aurovitas should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid exposure to extreme temperatures.
How is Lamivudina Aurovitas administered?+
Lamivudina Aurovitas is taken orally, usually with or without food, as directed by the prescribing clinician. The tablets are swallowed whole with a glass of water and the dosing schedule is based on the individual treatment plan.
What are the most serious risks associated with lamivudine?+
Serious adverse events, although rare, can include lactic acidosis, severe hepatotoxicity, and pancreatitis. Patients should be monitored for signs such as unexplained fatigue, abdominal pain, jaundice or rapid weight loss, and seek immediate medical attention if these occur.
Who should not use Lamivudina Aurovitas?+
Lamivudina Aurovitas is contraindicated in individuals with known hypersensitivity to lamivudine or any of the tablet’s excipients. Patients with severe renal impairment may require dose adjustment, and those with active liver disease should be closely monitored by their healthcare provider.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Lamivudine
Route
Oral Use
Manufacturer
Aurovitas Spain,s.A.U.
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU